Valuation: CALYXTPAR

Market Cap 98.59M 88M 81.79M 74.4M 140M 9.34B 142M 983M 384M 4.87B 370M 362M 15.59B P/E 2026 *
-0.89x
P/E 2027 * -1.7x
Enterprise Value 98.59M 88M 81.79M 74.4M 140M 9.34B 142M 983M 384M 4.87B 370M 362M 15.59B EV / Sales 2026 *
19x
EV / Sales 2027 * 7.93x
Free-Float
73.66%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 57 31/12/2013
Chief Executive Officer 63 23/02/2025
Chief Executive Officer 56 07/06/2026
Director TitleAgeSince
Chairman 72 31/12/2000
Director/Board Member 61 06/04/2026
Chairman 82 05/08/2025
Date Insider Type Main position Quantity % Market Cap. Importance
02/06/26 Free

Director

77,586 0.1477%
02/06/26 Free

Chief Executive Officer

77,586 0.1477%
02/06/26 Free

Director

64,748 0.1232%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+2.93% - - 98.59M
+3.46%+6.83%+31.94%+44.25% 258B
+3.03%+6.46%+12.32%+10.54% 163B
+1.81%+3.00%-1.78%+56.64% 151B
+2.65%+5.00%-54.83%-10.86% 63.97B
+1.91%+4.58%+20.80%+24.47% 50.78B
+1.59%+6.16%-12.73%-12.84% 50.94B
+0.89%+4.39%+25.71%+58.85% 49.49B
+5.27%+9.90%+8.93%+44.85% 50.68B
+1.73%+3.50%+33.62%+75.82% 43.64B
Average +1.26%+4.48%+7.11%+32.41% 88.1B
Weighted average by Cap. +1.55%+4.04%+11.41%+34.12%

Financials

2026 *2027 *
Net sales 5.19M 4.64M 4.31M 3.92M 7.37M 492M 7.51M 51.77M 20.25M 257M 19.49M 19.08M 821M 12.43M 11.09M 10.31M 9.38M 17.65M 1.18B 17.96M 124M 48.46M 614M 46.64M 45.66M 1.97B
Net income -66.51M -59.37M -55.18M -50.19M -94.43M -6.3B -96.13M -663M -259M -3.29B -250M -244M -10.52B -61.4M -54.81M -50.94M -46.34M -87.18M -5.82B -88.75M -612M -239M -3.03B -230M -226M -9.71B
Net Debt - -
Projected Income Statement - Annual - CALYXTPAR
Logo CALYXTPAR
Cibus, Inc. is an agricultural technology company that uses gene-editing technologies to develop plant traits in seeds. Its business is the development of plant traits for some of the agricultural food crops that help address specific productivity, profitability, sustainability, or yield challenges in farming. Its core technology propriety gene editing platform is called the Rapid Trait Development System (RTDS). It is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. It has a pipeline of five productivity traits. It has developed the productivity trait Pod Shatter Reduction (PSR) in Canola and Winter Oilseed Rape (WOSR) strengthens the sheath around the canola seeds. Its advanced productivity traits, Sclerotinia resistance and HT2 in Canola and WOSR, continue to progress and offer white mold disease resistance and broadleaf weed herbicide tolerance.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - CALYXTPAR
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.290USD
Average target price
14.33USD
Spread / Average Target
+1,011.11%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - CALYXTPAR
  1. Stock Market
  2. Stocks
  3. CLXT Stock